Why Glaucoma Patients Need Continued Vision Monitoring
Have you ever noticed that objects on the side of your vision seem harder to recognize, even though you can still see clearly when looking straight ahead? This can be one of the challenges associated with glaucoma, an eye disease that gradually damages the optic nerve and may cause permanent vision loss.
New research highlights another important concern: experiencing an initial episode of glaucoma progression does not necessarily mean the condition has reached a stable stage. A study published in JAMA Ophthalmology on October 22, 2026, found that 26.3% of eyes included in its recurrence analysis experienced another visual field deterioration event after an initial confirmed progression event.
The research, led by Davina A. Malek, M.D., and colleagues at the Bascom Palmer Eye Institute, University of Miami, examined how frequently glaucoma-related vision deterioration returned and which clinical characteristics were associated with a higher risk.
What the 2026 Glaucoma Study Found
The researchers used information from the Bascom Palmer Ophthalmic Registry, which contains clinical records from patients receiving routine eye care between 1998 and 2025.
The initial study population included 7,457 eyes from 5,086 patients diagnosed with open-angle glaucoma or suspected glaucoma. During a mean follow-up period of 12.4 years, 1,951 eyes, representing 26.2%, experienced an initial likely-progression event identified through Guided Progression Analysis.
For the recurrence investigation, the researchers selected 635 eyes with sufficient follow-up examinations and available intraocular pressure measurements after the first progression event.
Among these 635 eyes, 167 experienced another progression event, representing 26.3% of the analyzed group.
The researchers also calculated cumulative recurrence probabilities:
- Three years: 13.8% cumulative probability of recurrence.
- Five years: 25.6% cumulative probability.
- Ten years: 43.5% cumulative probability.
These percentages represent estimated recurrence over time, rather than the proportion of all glaucoma patients who will necessarily experience repeated deterioration.
The average interval between the first and second progression events was 3.2 years, with a standard deviation of 1.8 years.
Understanding Visual Field Progression
Glaucoma affects the optic nerve, which transmits visual information from the retina to the brain. Although elevated intraocular pressure is an important risk factor, the condition can also develop in people whose pressure measurements are within the statistically normal range.
One characteristic of glaucoma is progressive visual field loss. This means a person gradually loses the ability to see objects in certain areas, particularly around the edges of their field of vision.
Early damage can be difficult to recognize because central vision may remain relatively clear. Some individuals do not realize their peripheral vision has deteriorated until the disease becomes more advanced.
Visual field testing helps ophthalmologists identify these changes. Repeated examinations allow them to compare current results with previous measurements and determine whether the condition is progressing.
How Researchers Identified Recurrent Vision Deterioration
The study used Guided Progression Analysis (GPA), a clinical analysis method available through the Humphrey Field Analyzer.
This technology compares visual field examination results over time to identify patterns that suggest meaningful deterioration. The study defined likely progression as statistically significant worsening at three or more of the same test locations across three consecutive examinations.
This repeated-testing approach is important because visual field measurements can vary between appointments. A single abnormal result does not automatically establish that glaucoma has progressed.
The researchers also evaluated mean deviation (MD), a measurement used to summarize overall visual field sensitivity. More negative MD values generally indicate greater visual field damage.
Four Factors Associated With Repeat Glaucoma Progression
The analysis identified four independent factors associated with recurrent visual field deterioration.
1. Faster Previous Vision Deterioration
Eyes that had experienced faster visual field loss before their first progression event were more likely to experience another event.
The hazard ratio was 1.73 for every additional 1 decibel per year of faster mean deviation loss. This indicates a 73% higher estimated hazard of recurrence for each specified increase in the rate of previous deterioration.
The difference was particularly noticeable among faster-progressing eyes. Those with pre-event MD slopes faster than -1.0 dB per year had a recurrence rate of 42.7%, compared with 23.4% among slower-progressing eyes.
2. Higher Eye Pressure After Initial Progression
Intraocular pressure (IOP) measures the fluid pressure inside the eye. Higher pressure can contribute to optic nerve damage and is an important factor in glaucoma management.
The study found that higher average IOP following the first progression event was independently associated with recurrence. The hazard ratio was 1.09 for every additional 1 mm Hg.
This finding emphasizes the importance of continuing pressure measurements even after treatment has been adjusted following an initial deterioration event.
3. Less Advanced Damage at the First Event
Researchers also found that less negative mean deviation measurements at the first progression event were associated with a higher recurrence hazard.
The reported hazard ratio was 1.08 for every 1 dB increase in MD. This statistical association should not be interpreted to mean that advanced glaucoma is safer or that patients should delay treatment.
4. Older Age
Age was another independent factor associated with recurrence. The hazard ratio increased by 1.11 for every five-year increase in age.
These results suggest that ophthalmologists may need to consider a patient’s age, previous visual field deterioration, and pressure measurements together when assessing the possibility of further damage.
Can Lower Eye Pressure Help Reduce Recurrence?
One of the important findings involved the relationship between pressure reduction and subsequent visual field deterioration.
Researchers found that every additional 10% reduction in IOP was associated with an 11% lower hazard of recurrence. The reported hazard ratio was 0.89.
The findings support the importance of individualized pressure management. However, because this was an observational study, the results demonstrate an association rather than proving that pressure reduction alone prevents every future progression event.
Depending on the patient’s condition, glaucoma management may involve prescription eye drops, laser treatment, or surgery. An ophthalmologist determines the appropriate approach based on examination findings, disease severity, and individual treatment goals.
Interestingly, recurrence was still observed among patients whose pressure measurements were relatively low. This suggests that controlling IOP remains important but may not eliminate every risk associated with glaucoma.
Eye Examinations That Help Monitor Glaucoma
Regular eye examinations are essential because glaucoma-related damage can develop without noticeable symptoms.
Several diagnostic procedures help ophthalmologists evaluate the condition:
- Tonometry: Measures the pressure inside the eye.
- Automated visual field testing: Identifies areas of reduced vision and tracks changes over time.
- Optical coherence tomography (OCT): Provides detailed images of retinal nerve fiber layers and optic nerve structures.
- Gonioscopy: Examines the drainage angle to help classify the type of glaucoma.
- Dilated eye examination: Allows the doctor to assess the optic nerve for structural damage.
Combining these examinations gives eye specialists a more complete understanding of the patient’s condition than relying on eye pressure measurements alone.
When Should You See an Eye Doctor?
Anyone diagnosed with glaucoma should follow the examination schedule recommended by their ophthalmologist, even when their vision appears unchanged.
People with a documented progression event should discuss whether more frequent visual field testing or additional pressure monitoring is appropriate.
Seek urgent medical attention if you experience sudden vision loss, severe eye pain, a red eye, or blurred vision accompanied by nausea and vomiting. These symptoms may indicate an eye emergency, including acute angle-closure glaucoma.
Frequently Asked Questions About Glaucoma Progression
Does every glaucoma patient experience repeated vision deterioration?
No. In the study’s recurrence analysis, 167 of 635 eyes experienced another progression event. The remaining 468 did not have documented recurrence during their available follow-up. This does not guarantee that further progression will never occur.
How long does it take for glaucoma progression to happen again?
The average interval between the first and second progression events was 3.2 years. However, individual outcomes varied, and the study estimated cumulative recurrence probabilities of 13.8% at three years and 43.5% at ten years.
Does lowering eye pressure prevent further glaucoma damage?
Greater IOP reduction was associated with a lower recurrence hazard in the research. Nevertheless, pressure management cannot guarantee that progression will stop, so continued examinations remain necessary.
What Patients Should Remember About Long-Term Eye Health
The findings from the Bascom Palmer Eye Institute research demonstrate why glaucoma management requires continued attention after the first confirmed visual field progression event.
Although 26.3% of the selected eyes experienced recurrence, the results should be interpreted within the study’s limitations. The investigation involved a single academic medical center, and the recurrence analysis included only eyes with sufficient follow-up and available pressure measurements.
For patients, the most practical next step is to maintain regular appointments, review visual field test results with an ophthalmologist, and discuss whether current intraocular pressure targets remain appropriate.
Glaucoma damage can be permanent, but timely detection and appropriate management may help preserve remaining vision. Staying consistent with professional monitoring is an important part of protecting long-term eye health.
